SEC Form 4 · accession 0001209191-18-004591
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Pienta
Officer — Chief Medical Officer
Period of report
Dec 27, 2017
Accepted (ET)
Jan 19, 2018 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 27, 2017 | P | 2,000 | $7.50 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of the Issuer's common stock that were purchased in connection with the Issuer's initial public offering.